Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

News coverage of FDA warnings on pediatric antidepressant use and suicidality.

Barry CL, Busch SH.

Pediatrics. 2010 Jan;125(1):88-95. doi: 10.1542/peds.2009-0792. Epub 2009 Dec 7.

2.

The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial.

Brent DA, Greenhill LL, Compton S, Emslie G, Wells K, Walkup JT, Vitiello B, Bukstein O, Stanley B, Posner K, Kennard BD, Cwik MF, Wagner A, Coffey B, March JS, Riddle M, Goldstein T, Curry J, Barnett S, Capasso L, Zelazny J, Hughes J, Shen S, Gugga SS, Turner JB.

J Am Acad Child Adolesc Psychiatry. 2009 Oct;48(10):987-96. doi: 10.1097/CHI.0b013e3181b5dbe4.

3.

Managing drug-risk information--what to do with all those new numbers.

Avorn J, Schneeweiss S.

N Engl J Med. 2009 Aug 13;361(7):647-9. doi: 10.1056/NEJMp0905466. Epub 2009 Jul 27. No abstract available.

4.

Pediatric antidepressant use after the black-box warning.

Busch SH, Barry CL.

Health Aff (Millwood). 2009 May-Jun;28(3):724-33. doi: 10.1377/hlthaff.28.3.724.

5.

The impact of poor health on academic performance: New evidence using genetic markers.

Ding W, Lehrer SF, Rosenquist JN, Audrain-McGovern J.

J Health Econ. 2009 May;28(3):578-97. doi: 10.1016/j.jhealeco.2008.11.006. Epub 2008 Dec 25.

PMID:
19217678
6.

Technological innovation and inequality in health.

Glied S, Lleras-Muney A.

Demography. 2008 Aug;45(3):741-61.

7.

What's the Risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression.

Kleinman LC, Norton EC.

Health Serv Res. 2009 Feb;44(1):288-302. doi: 10.1111/j.1475-6773.2008.00900.x. Epub 2008 Sep 11.

8.

Suicide trends among youths aged 10 to 19 years in the United States, 1996-2005.

Bridge JA, Greenhouse JB, Weldon AH, Campo JV, Kelleher KJ.

JAMA. 2008 Sep 3;300(9):1025-6. doi: 10.1001/jama.300.9.1025. No abstract available.

PMID:
18768413
9.

Effects of Food and Drug Administration warnings on antidepressant use in a national sample.

Olfson M, Marcus SC, Druss BG.

Arch Gen Psychiatry. 2008 Jan;65(1):94-101. doi: 10.1001/archgenpsychiatry.2007.5.

PMID:
18180433
10.

Adolescent depression: diagnosis, treatment, and educational attainment.

Fletcher JM.

Health Econ. 2008 Nov;17(11):1215-35.

PMID:
18157910
11.

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.

Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ.

Am J Psychiatry. 2007 Sep;164(9):1356-63.

PMID:
17728420
12.

Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.

Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ.

Am J Psychiatry. 2007 Jun;164(6):884-91.

PMID:
17541047
13.

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.

Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF.

Arch Gen Psychiatry. 2007 Apr;64(4):466-72.

PMID:
17404123
14.

Suicidality in pediatric patients treated with antidepressant drugs.

Hammad TA, Laughren T, Racoosin J.

Arch Gen Psychiatry. 2006 Mar;63(3):332-9.

PMID:
16520440
15.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team.

JAMA. 2004 Aug 18;292(7):807-20.

PMID:
15315995
16.

Antidepressants and the risk of suicidal behaviors.

Jick H, Kaye JA, Jick SS.

JAMA. 2004 Jul 21;292(3):338-43.

PMID:
15265848

Supplemental Content

Support Center